Clinical Trial

A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer, FAST-GO Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates how the treatment for gastroesophageal cancer affects physical function in patients who receive chemotherapy as part of their treatment for gastroesophageal cancer.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2029-05-01 -> 2029-12-01 2026-07-08
minor Completion pushed: 2029-05-01 -> 2029-12-01 2026-07-08
Trial Details
NCT Number NCT07517211
Lead Sponsor Jonsson Comprehensive Cancer Center
Collaborators: National Institute on Aging (NIA)
Conditions Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 +4 more
Enrollment 72 participants
Start Date 2026-12-01
Primary Completion 2029-12-01 (estimated)
Study Completion 2029-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-07